ISMAEL MARTIN

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease NAPLES, FL NPI 1750353322

General Payments — all program years on this page

$10,603.04

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 487
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $925.91 across 37 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $925.9137

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $2,726.95142
2019 $3,415.90150
2020 $1,989.3598
2021 $1,003.3352
2022 $208.703
2023 $332.905
2024 $925.9137

Records — PY2024 (37)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078878028 Actelion Pharmaceuticals US, Inc. $22.54 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082363399 Tactile Systems Technology Inc $15.23 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104197403 AstraZeneca Pharmaceuticals LP $16.13 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104413737 AstraZeneca Pharmaceuticals LP $35.45 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104559866 AstraZeneca Pharmaceuticals LP $16.76 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104611918 AstraZeneca Pharmaceuticals LP $26.18 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104737507 AstraZeneca Pharmaceuticals LP $15.06 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105621179 AstraZeneca Pharmaceuticals LP $18.75 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105704646 AstraZeneca Pharmaceuticals LP $21.13 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105795174 AstraZeneca Pharmaceuticals LP $16.73 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111644774 Amgen Inc. $18.88 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114109087 Regeneron Healthcare Solutions, Inc. $22.53 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114109089 Regeneron Healthcare Solutions, Inc. $15.20 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114109091 Regeneron Healthcare Solutions, Inc. $23.39 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115751173 GlaxoSmithKline, LLC. $16.65 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116038252 GlaxoSmithKline, LLC. $20.22 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116654133 GlaxoSmithKline, LLC. $15.78 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118138512 Boehringer Ingelheim Pharmaceuticals, Inc. $21.47 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118138514 Boehringer Ingelheim Pharmaceuticals, Inc. $22.22 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133643270 Gilead Sciences, Inc. $15.66 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137630236 Takeda Pharmaceuticals U.S.A., Inc. $14.26 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137630238 Takeda Pharmaceuticals U.S.A., Inc. $15.27 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139685065 GENZYME CORPORATION $26.76 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139685081 GENZYME CORPORATION $22.03 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144988627 INOGEN, INC. $12.66 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145104310 Mallinckrodt Hospital Products Inc. $23.19 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145104314 Mallinckrodt Hospital Products Inc. $101.68 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146856165 Philips North America LLC $20.57 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147288948 Mylan Specialty L.P. $25.92 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147304396 Mylan Specialty L.P. $22.48 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147314816 Mylan Specialty L.P. $20.51 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147348782 Mylan Specialty L.P. $21.51 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148078706 Inspire Medical Systems, Inc. $78.19 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148078711 Inspire Medical Systems, Inc. $36.61 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148286077 Axsome Therapeutics, Inc. $30.80 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149453734 United Therapeutics Corporation $33.54 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149473216 United Therapeutics Corporation $23.97 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.